等待开盘 11-07 09:30:00 美东时间
0.000
0.00%
Pacira BioSciences partners with Molteni Farmaceutici to expand access to EXPAREL, a non-opioid postsurgical pain management solution, across European markets. Molteni will distribute and commercialize EXPAREL in key European countries, starting with Italy, Germany, Austria, and Poland, with the first sales expected in 2027. This collaboration aligns with Pacira's 5x30 growth strategy and Molteni's expansion goals, aiming to address unmet needs i...
10-05 12:00
对于发起人而言,De-spac能否完成关乎其行业声誉,而De-spac之后股价的走势则有更多的其他因素决定,就像一级市场的投资人,上市是关键,退出时的股价则有很多可以外部归因的要素。
2021-09-14 10:07